Magneto-reactance based detection of MnO nanoparticle-embedded Lewis lung carcinoma cells

Abstract

We demonstrate the capacity of detecting magnetically weak manganese oxide (MnO) nanoparticles and the Lewis lung carcinoma (LLC) cancer cells that have taken up these nanoparticles using a novel biosensor based on the magneto-reactance (MX) effect of a soft ferromagnetic amorphous ribbon with a microhole-patterned surface. While the magnetic moment of the MnO nanoparticles is relatively small, and a magneto-impedance based sensor fails to detect them in solution (0.05 mg/ml manganese oxide lipid micellar nanoparticles) and inside cells at low concentrations (8.25 Â 10 4 cells/ml), the detection of these nanoparticles and the LLC cells containing them is achieved with the MX-based sensor, which, respectively, reaches the detection sensitivity of $3.6% and 2.8% as compared to the blank cells. Since the MnO nanoparticles are a promising contrast agent for magnetic resonance imaging (MRI) of lung cells, the MX-based biosensing technique can be developed as a pre-detection method for MRI of lung cancer cells. V C 2015 AIP Publishing LLC. [http://dx.

A Model for the Magnetoimpedance Effect in Non-Symmetric Nanostructured Multilayered Films with Ferrogel Coverings

“…Magnetic biosensors for MNPs detection in natural tissues are a recent imaging area. Although the possibility of the MNP detection inside living cells was demonstrated almost 15 years ago [ 13 , 14 , 15 ], the detection of the MNPs inside cells (typical sizes are 10–100 μm) is quite similar to an “in vitro” detection of biomolecular labels [ 1 , 11 , 39 ]. The principle of the magnetic label detection is an evaluation of the sum of the stray fields of all magnetizable particles.…”

“…Although label-free magnetic detector prototypes were of special interest recently [ 7 , 8 ], a major part of the studies is related to the possibility to detect magnetizable nanoparticle concentrations [ 9 , 10 ]. There are different solutions for the detection: in “in vitro” experimental models [ 1 , 10 , 11 , 12 ], nanoparticles inside living cells [ 13 , 14 ], in continuous flow in medical devices or in blood flow [ 15 , 16 ], as a part of the implants or embedded into a natural tissue or artificial composites mimicking a natural tissue [ 5 , 17 , 18 , 19 ]. Many types of magnetic field sensors were tested in a simple “laboratory” device configuration just to ensure the proof of the concept.…”

Point-of-Care Diagnostics: Molecularly Imprinted Polymers and Nanomaterials for Enhanced Biosensor Selectivity and Transduction

“…However, MNPs have much more to offer. Since biological samples exhibit negligible magnetism, magnetic transduction with MNPs suffers from little background signal resulting in high sensitivity (154,155). Therefore, it is expected that magnetic transduction researchers will soon realize the potential in abandoning conventional analyte binding (e.g.…”

Anisotropic Mechanical and Giant Magneto-Impedance Properties of Cobalt-Rich Amorphous Ribbons

“…[8][9][10] The excellent GMI responses make them one of the best candidate materials for use in magnetic field sensors, 11,12 and these ribbons were being extensively used for the design of novel biosensing probes for highly sensitive detection of cancer cells and biomolecules. [13][14][15] Amorphous alloys are generally quasi-brittle materials since they do not have sufficient intrinsic micro-mechanisms to ease the high stress concentration that appears at the crack tip. In general they do not possess a strain hardening mechanism or any intrinsic crack propagation barrier such as grain boundaries.…”